The recent commotion about the risk of unexpectedmalignan-cy during myoma morcellation may have divergent conse-quences. Some are positive for future women’shealthcare, while others may be negative. On the positive side, the‘sar-coma awareness’will lead to improvements in the diagnosis of myometrial lesions including leiomyosarcoma and in the technical aspects of safer,‘spill-free’myoma removal. On the negative side, the fear of an unexpected sarcoma may lead to unnecessary, more invasive surgery and avoidance of minimal invasive surgery—out of an abundance of caution.